Shortening Biopharmaceutical Process Development Timelines with High-Throughput Approaches.

Jeanette Doerr, Ph.D., and Haiou Yang, Ph.D., of Avid Bioservices discuss the need for high-throughput process development and how the right biopharma CDMO can help.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: